Salem Erode rights issue: key dates, ISIN 2026

Record date set for rights issue eligibility

Salem Erode Investments Limited has fixed September 3, 2026 as the record date for its proposed rights issue. The record date determines which shareholders are eligible to apply for the new equity shares under the offer. Shareholders holding the company’s shares on this date, in line with the depository and exchange cut-offs, will be considered eligible. The disclosure is a key step in the rights issue process because it anchors the entitlement calculation. It also helps investors and brokers plan for the credit of rights entitlements in demat accounts. The company has indicated that the rights entitlements will be credited before the issue opens. This ensures eligible shareholders have sufficient time to decide whether to subscribe, renounce, or let the entitlements lapse within the permitted window.

ISIN announced for rights entitlements in demat

Alongside the record date, Salem Erode Investments disclosed the International Securities Identification Number (ISIN) for the rights entitlements. The ISIN for the rights entitlements is INE894E20010. Rights entitlements are typically credited to the demat accounts of eligible shareholders before the issue opening date. These entitlements represent the shareholder’s right to apply for equity shares under the rights offer, in the prescribed ratio. The ISIN is important operationally because it is how the entitlements are identified and traded or renounced through the market infrastructure. The company’s disclosure clarifies the mechanics: eligible shareholders will receive entitlements prior to the opening of the issue.

Issue size and structure remain unchanged

The company’s rights issue involves up to 1,14,65,520 equity shares at an issue price of ₹20 per share. At this price, the issue aggregates up to ₹22.931 crore (₹2,293.10 lakhs). The company has stated the rights issue will be offered on a 1:1 basis to eligible shareholders. The issue price includes a premium of ₹19 per share, implying a face value of ₹1 per share. The size and key terms, as described in the disclosure, remain consistent with previously reported aggregate value for the rights issue. The structure means that for every share held on the record date, an eligible shareholder is entitled to apply for one rights share.

Key dates: opening, renunciation, closing, and listing

Salem Erode Investments has also set out the schedule for the offer. The rights issue is scheduled to open on September 15, 2026. The last date for on-market renunciation is September 21, 2026, which is relevant for shareholders who do not wish to subscribe and prefer to transfer their entitlements. The issue closes on September 25, 2026. The company has indicated allotment finalization is scheduled for September 28, 2026, followed by listing on BSE on September 29, 2026. These dates provide a defined timeline for investors to take action based on their investment preferences and liquidity needs.

What shareholders should track in their demat accounts

For eligible shareholders, the most immediate operational step is the credit of rights entitlements into demat accounts ahead of September 15, 2026. Once credited, shareholders can use the entitlements to apply for shares or renounce them (including through on-market renunciation, within the specified deadline). Since the entitlements carry a separate ISIN (INE894E20010), shareholders will typically see a separate line item in their holdings. Investors should also note that corporate action processing can depend on correct demat and bank details, and broker-level timelines for applying or selling entitlements may vary within the exchange schedule. The company’s disclosure emphasises that the entitlements will be credited before the issue opens, aligning the credit with the start of the subscription window.

Board approvals and compliance disclosures

The company stated that its board approved the Letter of Offer and Application Form under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. This is part of the compliance pathway for rights issues in India. The disclosure also mentions trading window restrictions for designated persons. The trading window for designated persons was closed since August 25, 2026, and is slated to reopen 48 hours after the disclosure. These steps are typically linked to internal compliance requirements around unpublished price sensitive information.

Funding actions in 2026: NCD issuances alongside the rights issue

The rights issue timeline comes amid a series of debt fundraising actions by the company through private placements of unlisted secured redeemable non-convertible debentures (NCDs). Salem Erode Investments allotted NCDs aggregating to ₹3.695 crore on August 1, 2026, on a private placement basis. The Debenture and Bond Committee approved this allotment at its meeting held on August 1, 2026, which commenced at 02:00 PM IST and concluded at 02:30 PM IST, according to the disclosure. The company also stated that ICL Fincorp Limited, described as the holding company, took up ₹3.00 crore of this NCD issue. Separately, the board had earlier approved an issuance of secured redeemable NCDs aggregating ₹4.00 crore via private placement on July 23, 2026, described as 40,000 unlisted secured NCDs of face value ₹1,000 each, issued at par, to be raised in one or more tranches.

Financial snapshot and reported market reference points

Salem Erode Investments’ board meeting on August 13, 2026 approved unaudited standalone results for Q1 FY27. The company reported total income of ₹0.91 crore and a net loss of ₹1.31 crore for the quarter. Separately, the information also states the company reported a net loss of ₹4.8466 crore for the financial year ended March 31, 2026, widening from a net loss of ₹4.7193 crore in the previous year. A share price of ₹34 was also cited as the latest mentioned price, dated August 25, 2026. The company had earlier clarified to BSE that recent share price movements were attributable to the board’s approval of the rights issue and that it had no other undisclosed material information contributing to the movement, in response to a BSE query dated April 13, 2026.

Summary tables: terms and timeline

Market impact: what the disclosures change for investors

The record date and entitlement ISIN provide clarity on who can participate and how the entitlements will appear in demat accounts. The published schedule also creates fixed action points for shareholders, particularly around renunciation and subscription. The issue price of ₹20 per share and the disclosed issue size of up to ₹22.931 crore together define the maximum equity fundraising under this rights offer. The separate reference point of a ₹34 share price mentioned for August 25, 2026 offers context on the quoted market level cited in the material, though the disclosure itself does not state any expected price implications. The additional disclosures around NCD allotments, including the ₹3.695 crore allotment on August 1, 2026 and the holding company’s ₹3.00 crore participation, indicate the company has been using multiple funding channels in 2026.

Why this matters: connecting the rights issue with funding activity

A rights issue is a shareholder-linked fundraising route, and the operational details released now move the process closer to execution. The confirmation of the record date and the entitlement ISIN reduces uncertainty for shareholders who need to plan their next steps. The board approvals for the Letter of Offer and Application Form under SEBI ICDR also signal procedural progress. In parallel, the company’s repeated use of private placement NCDs, including the board-approved ₹4.00 crore NCD plan on July 23, 2026 and subsequent allotment of ₹3.695 crore on August 1, 2026, shows a pattern of capital raising through both equity-linked and debt instruments during the year.

Conclusion

Salem Erode Investments’ September 3, 2026 record date, entitlement ISIN (INE894E20010), and the September 15 to September 25, 2026 issue window set the practical framework for its ₹22.931 crore rights issue at ₹20 per share. The next confirmed milestones are allotment finalization on September 28, 2026 and listing on BSE on September 29, 2026.